Saffron - Depression (Depression)

The effects of saffron (Crocus sativus L.) on mental health parameters and C-reactive protein: A meta-analysis of randomized clinical trials

Study link https://pubmed.ncbi.nlm.nih.gov/31987241/

Health Goal Sleep, Anxiety, Depression, Early Awaking, Sleep Latency, Sleep Duration

Dietary Supplement Saffron

Study Level Meta-analysis

The effects of alcoholic extract of saffron (Crocus satious L.) on mild to moderate comorbid depression-anxiety, sleep quality, and life satisfaction in type 2 diabetes mellitus: A double-blind, randomized and placebo-controlled clinical trial

Study link https://pubmed.ncbi.nlm.nih.gov/30477839/

Health Goal Sleep, Anxiety, Depression, Early Awaking, Sleep Latency, Sleep Duration

Dietary Supplement Saffron

Study Level Randomized, Double Blind, Controlled Clinical Trial

affron ®, a standardised extract from saffron (Crocus sativus L.) for the treatment of youth anxiety and depressive symptoms: A randomised, double-blind, placebo-controlled study

Study link https://pubmed.ncbi.nlm.nih.gov/29510352/

Health Goal Anxiety, Depression

Dietary Supplement Saffron

Study Level Randomized, Double Blind, Controlled Clinical Trial

Saffron ( Crocus sativus) versus duloxetine for treatment of patients with fibromyalgia: A randomized double-blind clinical trial

Study link https://pubmed.ncbi.nlm.nih.gov/30456199/

Health Goal Anxiety, Depression

Dietary Supplement Saffron

Study Level Randomized, Double Blind, Controlled Clinical Trial

affron ® a novel saffron extract (Crocus sativus L.) improves mood in healthy adults over 4 weeks in a double-blind, parallel, randomized, placebo-controlled clinical trial

Study link https://pubmed.ncbi.nlm.nih.gov/28735826/

Health Goal Anxiety, Depression

Dietary Supplement Saffron

Study Level Randomized, Double Blind, Controlled Clinical Trial

A double-blind, randomized and placebo-controlled trial of Saffron (Crocus sativus L.) in the treatment of anxiety and depression

Study link https://pubmed.ncbi.nlm.nih.gov/27101556/

Health Goal Anxiety, Depression

Dietary Supplement Saffron

Study Level Randomized, Double Blind, Controlled Clinical Trial

Crocus sativus L. versus Citalopram in the Treatment of Major Depressive Disorder with Anxious Distress: A Double-Blind, Controlled Clinical Trial

Study link https://pubmed.ncbi.nlm.nih.gov/27701683/

Health Goal Anxiety, Depression

Dietary Supplement Saffron

Study Level Randomized, Double Blind, Controlled Clinical Trial

Effect of saffron supplementation on symptoms of depression and anxiety: a systematic review and meta-analysis

Study link https://pubmed.ncbi.nlm.nih.gov/31135916/

Health Goal Anxiety, Depression

Dietary Supplement Saffron

Study Level Meta-analysis

Crocus Sativus L. (saffron) versus sertraline on symptoms of depression among older people with major depressive disorders-a double-blind, randomized intervention study

Study link https://pubmed.ncbi.nlm.nih.gov/31669837/

Health Goal Depression

Dietary Supplement Saffron

Study Level Meta-analysis

Comparison of Crocus sativus L. and imipramine in the treatment of mild to moderate depression: a pilot double-blind randomized trial [ISRCTN45683816]

Study link https://pubmed.ncbi.nlm.nih.gov/15341662/

Health Goal Depression

Dietary Supplement Saffron

Study Level Randomized, Double Blind, Controlled Clinical Trial

Crocus sativus L. (petal) in the treatment of mild-to-moderate depression: a double-blind, randomized and placebo-controlled trial

Study link https://pubmed.ncbi.nlm.nih.gov/16979327/

Health Goal Depression

Dietary Supplement Saffron

Study Level Randomized, Double Blind, Controlled Clinical Trial

Crocus sativus L. (saffron) in the treatment of premenstrual syndrome: a double-blind, randomised and placebo-controlled trial

Study link https://pubmed.ncbi.nlm.nih.gov/18271889/

Health Goal Depression

Dietary Supplement Saffron

Study Level Randomized, Double Blind, Controlled Clinical Trial

Crocus sativus L. in the treatment of mild to moderate depression: a double-blind, randomized and placebo-controlled trial

Study link https://pubmed.ncbi.nlm.nih.gov/15852492/

Health Goal Depression

Dietary Supplement Saffron

Study Level Randomized, Double Blind, Controlled Clinical Trial

Efficacy of Crocus sativus (saffron) in treatment of major depressive disorder associated with post-menopausal hot flashes: a double-blind, randomized, placebo-controlled trial

Study link https://pubmed.ncbi.nlm.nih.gov/29332222/

Health Goal Depression

Dietary Supplement Saffron

Study Level Randomized, Double Blind, Controlled Clinical Trial

Hydro-alcoholic extract of Crocus sativus L. versus fluoxetine in the treatment of mild to moderate depression: a double-blind, randomized pilot trial

Study link https://pubmed.ncbi.nlm.nih.gov/15707766/

Health Goal Depression

Dietary Supplement Saffron

Study Level Randomized, Double Blind, Controlled Clinical Trial

Saffron (Crocus sativus L.) and major depressive disorder: a meta-analysis of randomized clinical trials

Study link https://pubmed.ncbi.nlm.nih.gov/24299602/

Health Goal Depression

Dietary Supplement Saffron

Study Level Meta-analysis

Comparison of petal of Crocus sativus L. and fluoxetine in the treatment of depressed outpatients: a pilot double-blind randomized trial

Study link https://pubmed.ncbi.nlm.nih.gov/17174460/

Health Goal Depression

Dietary Supplement Saffron

Study Level Randomized, Double Blind, Controlled Clinical Trial

A placebo controlled randomized clinical trial of Crocus sativus L. (saffron) on depression and food craving among overweight women with mild to moderate depression

Study link https://pubmed.ncbi.nlm.nih.gov/31602695/

Health Goal Depression

Dietary Supplement Saffron

Study Level Randomized, Controlled Clinical Trial

Comparison of Saffron versus Fluoxetine in Treatment of Mild to Moderate Postpartum Depression: A Double-Blind, Randomized Clinical Trial

Study link https://pubmed.ncbi.nlm.nih.gov/27595298/

Health Goal Depression

Dietary Supplement Saffron

Study Level Randomized, Double Blind, Controlled Clinical Trial

Saffron improved depression and reduced homocysteine level in patients with major depression: A Randomized, double-blind study

Study link https://pubmed.ncbi.nlm.nih.gov/29387573/

Health Goal Depression

Dietary Supplement Saffron

Study Level Randomized, Double Blind, Controlled Clinical Trial

A double-blind, randomized, placebo-controlled trial of saffron stigma (Crocus sativus L.) in mothers suffering from mild-to-moderate postpartum depression

Study link https://pubmed.ncbi.nlm.nih.gov/29157808/

Health Goal Depression

Dietary Supplement Saffron

Study Level Randomized, Double Blind, Controlled Clinical Trial

A randomized, double-blind, clinical trial comparing the efficacy and safety of Crocus sativus L. with fluoxetine for improving mild to moderate depression in post percutaneous coronary intervention patients

Study link https://pubmed.ncbi.nlm.nih.gov/24289892/

Health Goal Depression

Dietary Supplement Saffron

Study Level Randomized, Double Blind, Controlled Clinical Trial

Efficacy and Safety of Crocus sativus L. in Patients with Mild Cognitive Impairment: One Year Single-Blind Randomized, with Parallel Groups, Clinical Trial

Study link https://pubmed.ncbi.nlm.nih.gov/27472878/

Health Goal Depression

Dietary Supplement Saffron

Study Level Randomized, Controlled Clinical Trial

Petal and Stigma of Crocus sativus L. in the Treatment of Depression: A Pilot Double – blind Randomized Trial

Study link http://jmp.ir/article-1-560-fa.pdf

Health Goal Depression

Dietary Supplement Saffron

Study Level Randomized, Double Blind, Controlled Clinical Trial

The effects of saffron (Crocus sativus L.) on mental health parameters and C-reactive protein: A meta-analysis of randomized clinical trials

The effects of alcoholic extract of saffron (Crocus satious L.) on mild to moderate comorbid depression-anxiety, sleep quality, and life satisfaction in type 2 diabetes mellitus: A double-blind, randomized and placebo-controlled clinical trial

affron ®, a standardised extract from saffron (Crocus sativus L.) for the treatment of youth anxiety and depressive symptoms: A randomised, double-blind, placebo-controlled study

Saffron ( Crocus sativus) versus duloxetine for treatment of patients with fibromyalgia: A randomized double-blind clinical trial

affron ® a novel saffron extract (Crocus sativus L.) improves mood in healthy adults over 4 weeks in a double-blind, parallel, randomized, placebo-controlled clinical trial

A double-blind, randomized and placebo-controlled trial of Saffron (Crocus sativus L.) in the treatment of anxiety and depression

Crocus sativus L. versus Citalopram in the Treatment of Major Depressive Disorder with Anxious Distress: A Double-Blind, Controlled Clinical Trial

Effect of saffron supplementation on symptoms of depression and anxiety: a systematic review and meta-analysis

Crocus Sativus L. (saffron) versus sertraline on symptoms of depression among older people with major depressive disorders-a double-blind, randomized intervention study

Comparison of Crocus sativus L. and imipramine in the treatment of mild to moderate depression: a pilot double-blind randomized trial [ISRCTN45683816]

Crocus sativus L. (petal) in the treatment of mild-to-moderate depression: a double-blind, randomized and placebo-controlled trial

Crocus sativus L. (saffron) in the treatment of premenstrual syndrome: a double-blind, randomised and placebo-controlled trial

Crocus sativus L. in the treatment of mild to moderate depression: a double-blind, randomized and placebo-controlled trial

Efficacy of Crocus sativus (saffron) in treatment of major depressive disorder associated with post-menopausal hot flashes: a double-blind, randomized, placebo-controlled trial

Hydro-alcoholic extract of Crocus sativus L. versus fluoxetine in the treatment of mild to moderate depression: a double-blind, randomized pilot trial

Saffron (Crocus sativus L.) and major depressive disorder: a meta-analysis of randomized clinical trials

Comparison of petal of Crocus sativus L. and fluoxetine in the treatment of depressed outpatients: a pilot double-blind randomized trial

A placebo controlled randomized clinical trial of Crocus sativus L. (saffron) on depression and food craving among overweight women with mild to moderate depression

Comparison of Saffron versus Fluoxetine in Treatment of Mild to Moderate Postpartum Depression: A Double-Blind, Randomized Clinical Trial

Saffron improved depression and reduced homocysteine level in patients with major depression: A Randomized, double-blind study

A double-blind, randomized, placebo-controlled trial of saffron stigma (Crocus sativus L.) in mothers suffering from mild-to-moderate postpartum depression

A randomized, double-blind, clinical trial comparing the efficacy and safety of Crocus sativus L. with fluoxetine for improving mild to moderate depression in post percutaneous coronary intervention patients

Efficacy and Safety of Crocus sativus L. in Patients with Mild Cognitive Impairment: One Year Single-Blind Randomized, with Parallel Groups, Clinical Trial

Petal and Stigma of Crocus sativus L. in the Treatment of Depression: A Pilot Double – blind Randomized Trial

Our Company

Knowledge Base

Saffron – Depression (Depression)